XML 46 R34.htm IDEA: XBRL DOCUMENT v3.6.0.2
Share-Based Compensation (Tables)
6 Months Ended
Dec. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Share-Based Compensation Arrangement by Share Based Payment Award Options Outstanding

A summary of the stock option activity under the Company’s plans for the six months ended December 31, 2016 is as follows:

 

     Number
of
shares
     Weighted
average
exercise
price
 

Options outstanding at June 30, 2016

     8.2       $ 24.52   

Options granted

     —         $ —     

Less:

     

Options exercised

     (0.1    $ 13.39   

Options canceled or expired

     —         $ —     
  

 

 

    

Options outstanding at December 31, 2016

     8.1       $ 24.60   
  

 

 

    

Options exercisable at December 31, 2016

     7.6       $ 24.46   
Schedule of Share-Based Compensation Arrangement by Share Based Payment Award Restricted Stock Units Outstanding

A summary of the RSU activity under the Company’s plans for the six months ended December 31, 2016 is as follows:

 

     Number
of
shares
     Weighted
average
grant
date fair
value
 

RSUs outstanding at June 30, 2016

     1.4       $ 38.76   

RSUs granted

     1.1       $ 21.47   

Less:

     

RSUs vested

     (0.4    $ 20.26   

RSUs canceled

     —         $ —     
  

 

 

    

RSUs outstanding at December 31, 2016

     2.1       $ 33.30   
  

 

 

    
Schedule of Share-Based Compensation Recognized in Consolidated Statements of Operations

Share-based compensation expense recognized and included in the condensed consolidated statements of income and comprehensive income was allocated as follows:

 

     Three months ended
December 31,
     Six months ended
December 31,
 
     2016      2015      2016      2015  

Cost of molecular diagnostic testing

   $ 0.3       $ 0.3       $ 0.4       $ 0.5   

Cost of pharmaceutical and clinical services

     0.0         0.1         0.1         0.2   

Research and development expense

     1.4         1.2         3.0         2.8   

Selling, general, and administrative expense

     5.7         6.1         11.7         12.8   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total share-based compensation expense

   $ 7.4       $ 7.7       $ 15.2       $ 16.3